JPMorgan Starts Landos Biopharma (LABP) at Neutral

March 1, 2021 2:20 AM EST Send to a Friend
JPMorgan analyst Jessica Fye initiates coverage on Landos Biopharma (NASDAQ: LABP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login